Diphtheria, tetanus, & acellular pertussis – (DTaP: <7 yrs)
Recommended Age Range:
2, 4, 6, 15-18 months, 4-6 years
Common Side Effects:
Fever, irritability, drowsiness, loss of appetite
Research & Testing History:
Licensed in 1991 after trials comparing with older DTP; higher safety profile confirmed.
Use History:
Routine use since 1991
Trial Size:
~30,000 infants
Years on Schedule:
~34 years
Known Safety Concerns:
Rare febrile seizures
Ingredients:
Diphtheria toxoid, tetanus toxoid, acellular pertussis antigens, aluminum phosphate, formaldehyde, polysorbate 80, sodium chloride.
Learn More Here